1. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer
   María A. Rodríguez-Hernández et al, 2020, Redox Biology CrossRef
2. Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia
   Hélène Cabanas et al, 2018, Oncotarget CrossRef
3. A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug‐resistant leukemia cells
   Yinghui Li et al, 2020, The FASEB Journal CrossRef
4. Hypercalcemia in Chronic Myeloid Leukemia: An Unusual Presentation
   Khushboo Agarwal et al, 2023, Indian Journal of Medical and Paediatric Oncology CrossRef
5. Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers
   Fenglian Yang et al, 2020, BMC Cancer CrossRef
6. Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia
   Mythreyi Narasimhan et al, 2022, Journal of Cell Communication and Signaling CrossRef
7. NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings
   Matteo Centonze et al, 2018, Translational Oncology CrossRef